Nightingale Health and Genom to launch risk detection test in Croatia

Nightingale Health and Genom have partnered to introduce a blood-based risk detection test to clinics and laboratories throughout Croatia. Genom will make the test available to its healthcare network while Nightingale Health will analyse the blood samples. The test generates a ten-year risk estimate for five chronic conditions from a single blood sample. Credit: Nuttapong punna / Shutterstock.com. Nightingale Health and Genom have entered a partnership to introduce a blood-based risk detection test to clinics and laboratories throughout Croatia. The collaboration marks Nightingale Health’s entry into the Croatian market. Artificial Intelligence in Healthcare: Automated Genetic Screening Reports Internet of Things…

Source: Medical Device Network